Human Physiology II: Respiratory, Digestive, and Endocrine Systems
Learning Objectives
By the end of this chapter, you should be able to:
- Describe gas exchange at the alveolus and explain why it matters for inhaled and IV drug delivery.
- Trace the path of an orally administered drug through the GI tract and explain each absorption checkpoint.
- Explain first-pass metabolism and predict which drugs are most affected by it.
- Describe the hypothalamic-pituitary axis and explain how it regulates downstream endocrine glands.
- Explain insulin signaling and connect it to the pharmacology of diabetes treatment.
- Compare oral, inhaled, and parenteral routes in terms of the physiology each one exploits or bypasses.
Quick Answer
The respiratory, digestive, and endocrine systems are the three physiological gateways that most drugs pass through — the lungs for inhaled therapy and gas exchange, the GI tract for oral absorption and first-pass metabolism, and the endocrine system for hormone-based regulation and hormone-replacement drugs. Nearly every question about "why does this drug need to be taken this way" or "why does this drug interact with that hormone" traces back to how these three systems normally function. Understanding them as regulated, dynamic systems — not static plumbing — is what lets you predict how disease and drugs change their behavior.
Core Concepts
Gas Exchange and the Respiratory Route
Definition: Gas exchange occurs at the alveoli, tiny air sacs surrounded by a dense capillary network, where oxygen diffuses from air into blood and carbon dioxide diffuses from blood into air across a very thin (about 0.5 micrometer) membrane.
Explanation: This membrane is thin specifically to maximize diffusion efficiency, and the same thinness that makes gas exchange fast also makes the lungs an efficient route for drug absorption — inhaled drugs can enter systemic circulation almost as quickly as an IV injection, without needing to cross the gut wall or survive hepatic first-pass metabolism.
Example: Inhaled albuterol acts on bronchial smooth muscle within minutes because it's deposited directly in the airways near its target receptors, with minimal systemic absorption needed for local effect.
Real-world example: General anesthetics like sevoflurane are given by inhalation precisely because the alveolar-capillary membrane allows extremely rapid uptake into the blood and, from there, rapid access to the brain — a property essential for controllable anesthesia depth.
Why it matters: The inhalation route is chosen specifically when speed, local lung effect, or avoidance of first-pass metabolism is desired — understanding alveolar anatomy explains why.
Common misunderstanding: Students often think inhaled drugs act "only locally" in the lungs. Many inhaled drugs (like anesthetic gases) are absorbed systemically and act on distant organs, particularly the brain, precisely because of the alveolar membrane's efficiency.
The GI Tract and Oral Drug Absorption
Definition: The gastrointestinal tract is a continuous tube from mouth to anus (oral cavity, esophagus, stomach, small intestine, large intestine) responsible for digesting food and absorbing nutrients — and, for orally administered drugs, absorbing the drug itself.
Explanation: After swallowing, a drug passes through the stomach (acidic environment, can degrade acid-labile drugs), then the small intestine, where most absorption occurs across the intestinal epithelium into the hepatic portal vein. From there, blood carries the drug directly to the liver before it ever reaches systemic circulation — this is first-pass metabolism, and it can inactivate a significant fraction of an oral dose before the drug has a chance to act anywhere else in the body.
Example: Omeprazole is formulated as an enteric-coated capsule specifically because it is acid-labile and would be destroyed by stomach acid if released too early — the coating delays release until the drug reaches the more neutral pH of the small intestine.
Real-world example: Nitroglycerin is given sublingually (under the tongue) rather than orally for angina specifically to bypass the GI tract and hepatic first-pass metabolism, which would otherwise destroy nearly all of the dose before it reached the heart.
Why it matters: First-pass metabolism explains why some drugs have low oral bioavailability and require much higher oral doses than IV doses to achieve the same effect, and why some drugs cannot be given orally at all.
Common misunderstanding: Students often assume that "absorbed" and "bioavailable" mean the same thing. A drug can be well absorbed across the intestinal wall but still have low bioavailability if the liver metabolizes most of it before it reaches systemic circulation.
The Hypothalamic-Pituitary Axis
Definition: The hypothalamus releases regulatory hormones that control the anterior pituitary gland, which in turn releases trophic hormones that regulate peripheral endocrine glands (thyroid, adrenal cortex, gonads). This creates a hierarchical, negative-feedback control system.
Explanation: For example, the hypothalamus releases TRH (thyrotropin-releasing hormone), which stimulates the pituitary to release TSH (thyroid-stimulating hormone), which stimulates the thyroid to release T3/T4. Rising T3/T4 levels then feed back to suppress both TRH and TSH release — a classic negative feedback loop that keeps hormone levels within a narrow range.
Example: This is like a thermostat: when the "temperature" (hormone level) gets too high, the "control system" (hypothalamus/pituitary) reduces its signal to bring it back down.
Real-world example: In hypothyroidism, low T3/T4 fails to suppress TSH, so TSH rises — this is exactly why a high TSH with low free T4 is the classic lab pattern used to diagnose primary hypothyroidism, and why levothyroxine dosing is titrated based on TSH levels, not symptoms alone.
Why it matters: Nearly every hormone-replacement or hormone-suppressing drug (levothyroxine, corticosteroids, hormonal contraceptives, GnRH agonists for prostate cancer) works by manipulating a point along this feedback axis.
Common misunderstanding: Students often think giving more hormone is always straightforwardly "good" if a patient is deficient. In reality, exogenous hormone administration suppresses the body's own axis (e.g., long-term corticosteroid use suppresses the hypothalamic-pituitary-adrenal axis), which is why such drugs often require tapering rather than abrupt discontinuation.
Insulin Signaling and Glucose Regulation
Definition: Insulin, secreted by pancreatic beta cells in response to rising blood glucose, binds insulin receptors on target cells (muscle, fat, liver) and triggers translocation of GLUT4 glucose transporters to the cell membrane, allowing glucose to enter the cell.
Explanation: Without adequate insulin signaling — whether from insufficient insulin production (type 1 diabetes) or receptor/post-receptor resistance (type 2 diabetes) — glucose accumulates in the blood while cells are effectively starved of glucose despite its abundance nearby.
Example: It's like a truck (glucose) waiting outside a warehouse (the cell) with the loading dock door (GLUT4 transporter) stuck closed because the key (insulin) either isn't available or the lock (receptor) doesn't respond properly to it.
Real-world example: Metformin, the first-line drug for type 2 diabetes, works partly by reducing hepatic glucose production and improving peripheral insulin sensitivity — it doesn't replace insulin, it helps the existing signaling work more effectively, which is a fundamentally different strategy from insulin injections used in type 1 diabetes.
Why it matters: Understanding exactly where the insulin signaling pathway fails (production vs. resistance) explains why type 1 and type 2 diabetes are treated so differently, and why some type 2 drugs (sulfonylureas, GLP-1 agonists, metformin) target different points in glucose regulation.
Common misunderstanding: Students often conflate type 1 and type 2 diabetes as "the same disease at different severities." They are mechanistically distinct — type 1 is autoimmune destruction of insulin-producing cells (absolute deficiency), while type 2 is primarily insulin resistance with relative deficiency, requiring different first-line therapeutic strategies.
Visual Learning: Three Gateways for Drug Action
Real-World Applications
Pharmacists explain to patients why nitroglycerin is placed under the tongue and not swallowed, why enteric-coated tablets shouldn't be crushed, and why a patient tapering off long-term prednisone needs a slow schedule rather than stopping abruptly — all direct applications of GI absorption physiology and the hypothalamic-pituitary-adrenal axis. In diabetes care, understanding that metformin improves insulin sensitivity while insulin injections replace the hormone entirely is the difference between counseling a type 2 patient correctly and confusing two fundamentally different treatment strategies.
Key Terms
| Term | Definition | Why It Matters in Pharmacy |
|---|---|---|
| Alveolus | Tiny air sac where gas exchange occurs | Site of rapid drug absorption for inhaled therapies |
| First-pass metabolism | Hepatic metabolism of an oral drug before reaching systemic circulation | Explains low oral bioavailability of many drugs |
| Bioavailability | Fraction of administered drug that reaches systemic circulation unchanged | Determines dose adjustment between routes (e.g., oral vs. IV) |
| Hypothalamic-pituitary axis | Hierarchical hormone control system with negative feedback | Basis for hormone-replacement and hormone-suppressing drugs |
| Negative feedback | Regulatory loop where rising hormone levels suppress further release | Explains why TSH rises in hypothyroidism |
| GLUT4 | Glucose transporter moved to cell membrane in response to insulin | Explains cellular mechanism disrupted in diabetes |
| Insulin resistance | Reduced cellular response to insulin despite adequate levels | Core mechanism in type 2 diabetes, target of metformin |
| Enteric coating | Coating that delays drug release until past the stomach | Protects acid-labile drugs (e.g., omeprazole) from gastric acid |
Common Mistakes
Misconception 1: "Inhaled drugs only act locally in the lungs." Why it's wrong: The thin alveolar-capillary membrane allows many inhaled drugs to be absorbed systemically and act on distant organs. Correct understanding: Inhaled anesthetics, for example, rely on rapid systemic absorption through the alveoli to reach the brain — the lung is often a route to the whole body, not just a local target.
Misconception 2: "If a drug is well absorbed from the gut, it will be highly bioavailable." Why it's wrong: Absorption and bioavailability are different — first-pass hepatic metabolism can inactivate a large fraction of an absorbed drug before it reaches systemic circulation. Correct understanding: A drug can be nearly 100% absorbed across the intestinal wall but have very low oral bioavailability due to extensive first-pass metabolism, which is why some drugs (like nitroglycerin) must avoid the oral-hepatic route entirely.
Misconception 3: "Type 1 and type 2 diabetes are essentially the same disease, just different severities." Why it's wrong: They have distinct underlying mechanisms — autoimmune beta-cell destruction versus insulin resistance. Correct understanding: Type 1 diabetes requires exogenous insulin because the body produces little to none; type 2 diabetes often starts with lifestyle changes and insulin-sensitizing drugs like metformin because the pancreas still produces insulin, but the body's cells respond to it poorly.
Comparison and Connections
| Feature | Oral Route | Inhalation Route | Sublingual Route |
|---|---|---|---|
| First-pass metabolism | Yes, significant | No | No (bypasses GI and liver) |
| Onset of action | Slower (minutes to hours) | Very fast (seconds to minutes) | Fast (minutes) |
| Best suited for | Chronic, stable dosing | Local lung effect or rapid systemic access | Emergency/rapid systemic access (e.g., angina) |
| Example drug | Levothyroxine | Albuterol, sevoflurane | Nitroglycerin |
Practice Questions
Recall
- Define first-pass metabolism and name one drug administration route that avoids it. Answer guidance: Hepatic metabolism of an orally absorbed drug before it reaches systemic circulation; avoided by sublingual, inhaled, IV, or transdermal routes.
- What hormone does the pituitary release to stimulate the thyroid, and what hormones does the thyroid release in response? Answer guidance: TSH (thyroid-stimulating hormone) stimulates release of T3 and T4.
Understanding 3. Explain why enteric coating is used for a drug like omeprazole. Answer guidance: Omeprazole is acid-labile and would be degraded by stomach acid; the enteric coating delays drug release until it reaches the more neutral pH environment of the small intestine. 4. Explain why long-term corticosteroid therapy requires a tapering schedule rather than abrupt discontinuation. Answer guidance: Exogenous corticosteroids suppress the hypothalamic-pituitary-adrenal axis via negative feedback; abrupt discontinuation doesn't give the suppressed axis time to resume normal cortisol production, risking adrenal insufficiency.
Application 5. A patient with angina is prescribed nitroglycerin. Why is it given sublingually instead of as a swallowed tablet? Answer guidance: Sublingual administration bypasses the GI tract and hepatic first-pass metabolism, allowing rapid absorption directly into systemic circulation for fast relief of angina symptoms. 6. A patient with type 2 diabetes is started on metformin rather than insulin. Using insulin signaling physiology, explain why this makes sense as first-line therapy. Answer guidance: Type 2 diabetes primarily involves insulin resistance with the pancreas still producing insulin; metformin improves insulin sensitivity and reduces hepatic glucose output rather than replacing insulin, addressing the underlying resistance rather than treating it as an absolute deficiency.
Analysis 7. Compare the physiological rationale for choosing an inhaled general anesthetic versus an IV general anesthetic in terms of onset and control. Answer guidance: Both allow rapid systemic access (bypassing GI absorption), but inhaled anesthetics allow continuous, titratable control via adjusting inspired concentration, while IV anesthetics depend on bolus or infusion dosing — both exploit rapid vascular access, but through different physiological routes (alveolar membrane vs. direct venous access). 8. A drug has excellent GI absorption (95%) but only 10% oral bioavailability. Analyze what this tells you about the drug and what alternative route might be considered. Answer guidance: The large gap between absorption and bioavailability indicates extensive first-pass hepatic metabolism; an alternative route that bypasses the liver's first pass — such as sublingual, transdermal, or IV administration — would likely achieve much higher effective drug levels for the same dose.
FAQ
Q: Why do some drugs need to be given by injection instead of orally? A: Often because they would be destroyed by stomach acid or digestive enzymes, poorly absorbed across the gut wall, or extensively metabolized by the liver before reaching systemic circulation (first-pass effect).
Q: Is first-pass metabolism always a problem? A: Not always — some drugs are inactive "prodrugs" until the liver converts them into their active form, so first-pass metabolism can be a required activation step rather than a loss of drug.
Q: Why does TSH rise in hypothyroidism instead of falling? A: Because the negative feedback loop is driven by thyroid hormone (T3/T4) levels; when these are low, there's less suppression of the pituitary, so TSH rises as the body tries to stimulate the underactive thyroid.
Q: Why can't dopamine be given for Parkinson's disease the way insulin is given for diabetes? A: (Cross-reference to nervous system physiology) Dopamine cannot cross the blood-brain barrier, so a precursor (levodopa) is used instead — a different barrier problem than diabetes, where insulin, given by injection, can act directly on peripheral tissues without needing to cross the BBB.
Q: Why do type 1 and type 2 diabetes need different first-line drugs? A: Because they have different underlying mechanisms — insulin deficiency versus insulin resistance — so treatment targets different points in glucose regulation physiology.
Quick Revision
- Gas exchange occurs at the alveoli across a very thin membrane, which also makes inhalation an efficient drug delivery route.
- Inhaled drugs can act locally in the lungs or be absorbed systemically to reach distant organs (e.g., anesthetics reaching the brain).
- Oral drugs are absorbed mainly in the small intestine, then pass through the liver via the hepatic portal vein (first-pass metabolism) before reaching systemic circulation.
- Bioavailability accounts for both absorption and first-pass metabolism — a drug can be well absorbed but poorly bioavailable.
- Sublingual, IV, inhaled, and transdermal routes all bypass first-pass hepatic metabolism.
- The hypothalamic-pituitary axis uses negative feedback to regulate thyroid, adrenal, and gonadal hormone levels.
- Exogenous hormone therapy suppresses the body's own axis — this is why steroids are tapered, not stopped abruptly.
- Insulin triggers GLUT4 transporter movement to allow glucose into cells; failure can be due to insufficient insulin (type 1) or resistance (type 2).
- Metformin improves insulin sensitivity; it does not replace insulin the way injectable insulin does.
- Enteric coatings protect acid-labile drugs from destruction in the stomach.
Related Topics
Prerequisites: Human Physiology I (nervous and circulatory systems), Human Anatomy II (skeletal and muscular systems)
Related Topics: Pathophysiology (disease mechanisms in these systems), Applied Anatomy and Physiology
Next Topics: Pathophysiology — Disease Mechanisms; Applied Anatomy and Physiology — Integrated Drug Action